Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review.
Camaj A, Leone PP, Colombo A, Vinayak M, Stone GW, Mehran R, Dangas G, Kini A, Sharma SK.
JAMA Cardiol. 2025 Feb 1;10(2):189-198. doi: 10.1001/jamacardio.2024.4244.
Mid-term clinical outcomes of new generation drug-eluting stents for treatment of diffuse coronary artery disease.
Çoner A, Çiçek D, Akıncı S, Balcıoğlu S, Altın C, Müderrisoğlu H.
Turk Kardiyol Dern Ars. 2018 Dec;46(8):659-666. doi: 10.5543/tkda.2018.10.5543/tkda.2018.62678.
Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery.
Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, Airoldi F, Montorfano M, Michev I, Colombo A.
J Am Coll Cardiol. 2005 May 17;45(10):1570-3. doi: 10.1016/j.jacc.2005.01.049.
Impact of the ultra-long 48 mm drug-eluting stent on procedural and clinical outcomes in patients with diffuse long coronary artery disease.
Youn YJ, Jeon HS, Kim YI, Lee JH, Park YJ, Cho DH, Son JW, Lee JW, Ahn MS, Ahn SG, Kim JY, Yoo BS, Lee SH, Yoon J.
Clin Cardiol. 2023 Apr;46(4):416-424. doi: 10.1002/clc.23997. Epub 2023 Feb 20.
Edge-to-Edge Technique to Minimize Ovelapping of Multiple Bioresorbable Scaffolds Plus Drug Eluting Stents in Revascularization of Long Diffuse Left Anterior Descending Coronary Artery Disease.
Rigatelli G, Avvocata FD, Ronco F, Giordan M, Roncon L, Caprioglio F, Grassi G, Faggian G, Cardaioli P.
J Interv Cardiol. 2016 Jun;29(3):275-84. doi: 10.1111/joic.12287.
Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease.
Marchetta M, Sasso S, Paragliola V, Maffi V, Chiricolo G, Massaro G, Russo G, Benedetto D, Muscoli S, Colonna G, Mandurino-Mirizzi A, Cortese B, Sangiorgi GM, Andò G.
J Cardiovasc Dev Dis. 2025 May 5;12(5):176. doi: 10.3390/jcdd12050176.
Long-term outcomes after stent implantation in very small vessel coronary artery disease.
Liu ES, Yang TH, Tai TH, Chiang CH, Cheng CC, Huang WC, Mar GY, Kuo FY.
Clin Cardiol. 2023 Apr;46(4):431-440. doi: 10.1002/clc.24000. Epub 2023 Feb 23.
Intravascular ultrasound-guided percutaneous coronary intervention improves the clinical outcome in patients undergoing multiple overlapping drug-eluting stents implantation.
Ahn SG, Yoon J, Sung JK, Lee JH, Lee JW, Youn YJ, Ahn MS, Kim JY, Yoo BS, Lee SH, Choe KH.
Korean Circ J. 2013 Apr;43(4):231-8. doi: 10.4070/kcj.2013.43.4.231. Epub 2013 Apr 30.
Novel ultra-long (48 mm) everolimus-eluting stent for diffusely coronary vessels disease.
Genuardi L, Burzotta F, Russo G, Shoeib O, Verdirosi D, Aurigemma C, Niccoli G, Porto I, Leone AM, Trani C.
Minerva Cardioangiol. 2019 Apr;67(2):87-93. doi: 10.23736/S0026-4725.19.04879-5. Epub 2019 Mar 19.
One-year Outcomes of XIENCE Skypoint 48-mm Drug-Eluting Stents in Long Coronary Lesions: The SPIRIT 48 Trial.
Park KE, Wu CJ, Chehab B, Maksoud A, Bertolet B, Ying SW, Simoes T, Pingle SC, Chang CJ.
J Soc Cardiovasc Angiogr Interv. 2023 May 18;2(4):101001. doi: 10.1016/j.jscai.2023.101001. eCollection 2023 Jul-Aug.
